Cabaletta Bio (CABA) Cash from Investing Activities (2019 - 2025)

Cabaletta Bio's Cash from Investing Activities history runs 7 years deep, the most recent figure standing at $49.8 million for Q4 2025.

• In Q4 2025, Cash from Investing Activities rose 310.71% year-over-year to $49.8 million; the TTM figure through Dec 2025 stood at -$50.3 million (down 206.3% YoY), while the FY2025 annual figure was -$50.3 million, down 206.3% from the prior year.
• Cash from Investing Activities was $49.8 million for Q4 2025 at Cabaletta Bio, up from -$50.1 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $49.8 million in Q4 2025 to a low of -$50.1 million in Q3 2025.
• Historically, Cash from Investing Activities has averaged -$2.3 million across 5 years, with a median of $938000.0 in 2021.
• The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities sank 5261.02% in 2023, then jumped 18941.54% in 2024.
• A 5-year view of Cash from Investing Activities shows it stood at $849000.0 in 2021, then plunged by 137.22% to -$316000.0 in 2022, then surged by 459.49% to $1.1 million in 2023, then surged by 967.25% to $12.1 million in 2024, then jumped by 310.71% to $49.8 million in 2025.
• The last three Cash from Investing Activities figures came in at $49.8 million (Q4 2025), -$50.1 million (Q3 2025), and -$49.2 million (Q2 2025), per Business Quant data.